RTTNews | Jan 12, 2021 09:57AM EST

09:57 Tuesday, January 12, 2021 (RTTNews.com) - Shares of micro-cap company Biomerica Inc. (BMRA) gained 30% on Tuesday morning after the biomedical technology company said its new Covid-19 antigen test received CE mark.

BMRA is currently trading at $6.79, up $1.65 or 32.06%, on the Nasdaq.

Biomerica said it has received CE Mark for its new COVID-19 Rapid Antigen Test for detection of COVID-19 infection. The company has already received its first European orders and plans to ship the first part of these orders in the coming weeks.

Read the original article on RTTNews ( https://www.rttnews.com/3159853/stock-alert-biomerica-jumps-30-after-covid-19-antigen-test-receives-ce-mark.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved